αDβ2 as a novel target of experimental polymicrobial sepsis
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.1059996
Abstract: Since sepsis was defined three decades ago, it has been a target of intensive study. However, there is no specific sepsis treatment available, with its high mortality and morbidity. αDβ2 (CD11d/CD18) is one of the… read more here.
Keywords: sepsis; target experimental; experimental polymicrobial; polymicrobial sepsis ... See more keywords